We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Immunology

Image: The Immune Reveal point-of-care system goes beyond routine lab tests (Photo courtesy of Immune IQ)

First-Ever POC Analyzer Reads Patient's Immune System to Detect Diseases Before Symptoms Present

A breakthrough point-of-care diagnostic platform that leverages the power of the human immune system is poised to address the two main challenges associated with sepsis: broad screening and rapid identification. More...
19 May 2023
Image: The single automated device can run hematology, clinical chemistry, and immunoassays subsystems in parallel (Photo courtesy of Freepik)

Single Automated Analyzer to Bring Full Suite of Diagnostics to Wherever Patients Are

A novel platform that delivers swift results using minimal blood volumes incorporates technology that facilitates automation and adaptable form factors outside centralized labs, bridging the gap between diagnostics and treatment. More...
09 May 2023
A study has found that ChemoID platform-predicted treatments led to longer survival (Photo courtesy of Freepik)

Cancer Stem Cell Test Improves Survival of Patients with Deadly Brain Tumor

A new study has found that a cancer stem cell test can accurately determine more effective treatments, resulting in increased survival rates for patients with glioblastoma, a lethal brain tumor. More...
09 May 2023
Image: The new discovery could improve survival of bladder cancer patients (Photo courtesy of Freepik)

Biomarker Signature Test Predicts Which Tumors Will Respond to Immunotherapy

In a breakthrough that could enhance bladder cancer patients' survival, researchers have now developed a biomarker signature test to predict which tumors will be responsive to immunotherapy. More...
28 Apr 2023
Image: Blood-based biomarkers can accurately predict neuroendocrine tumor response to radiopharmaceutical therapy (Photo courtesy of Freepik)

Simple Blood Test Predicts Neuroendocrine Tumor Response to Radiopharmaceutical Therapy

A new study has revealed that a simple blood test can supply doctors with crucial information to ascertain if peptide receptor radionuclide therapy (PRRT) is likely to be effective in patients with neuroendocrine cancer. More...
11 Apr 2023
Image: New microfluidics physics-based device to predict cancer therapy response (Photo courtesy of University of Barcelona)

Fast, Fully Automated Microfluidic Device Predicts Effectiveness of Cancer Treatment

A microfluidic device can quickly and automatically predict the effectiveness of cancer treatment by using a tiny amount of cells from biopsies and without the need for specialized technical staff. More...
03 Apr 2023
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Researchers have discovered that a genetic test, an established part of standard care in the UK and globally to predict patients' responses to other targeted cancer drugs, can also predict whether chemotherapy will work for bowel cancer patients. This discovery could aid in sparing patients from unnecessary toxicity and debilitating side effects by avoiding treatments that will not benefit them. More...
06 Mar 2023
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Vaginal pH Screening Kit
Vaginal pH Screening Kit
New
Syphilis Infection Test
IMPACT RPR


The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.
Copyright © 2000-2025 Globetech Media. All rights reserved.